16 Results

People

  1. Lee
    Lee
  2. Brentjens
    Brentjens
  3. Lee
    Lee
  4. Sadelain
    Sadelain
  5. Mueller
    Mueller
  6. Dutta
    Dutta
  7. Gelblum
    Gelblum
  8. Lee
    Lee
  9. Wolden
    Wolden
  10. Fury
    Fury

Groups

  1. Center for Hematologic Malignancies (10)
  2. Department of Medicine (10)
  3. GSK Faculty (8)
  4. Hematologic Malignancies, Division of (8)
  5. Adult Leukemia (7)
  6. Hematologic Malignancies Research (7)
  7. Radiation Oncology, Department of (7)
  8. Molecular Pharmacology and Chemistry Program Faculty (6)
  9. Sloan Kettering Institute Faculty (6)
  10. Survivorship Research (5)
  1. "James Lee"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (7)
Groups
  1. Center for Hematologic Malignancies (10)
  2. Department of Medicine (10)
  3. GSK Faculty (8)
  4. Hematologic Malignancies, Division of (8)
  5. Adult Leukemia (7)
  6. Hematologic Malignancies Research (7)

More Groups

People
  1. James Lee (16)
  2. Renier Brentjens (7)
  3. Michel Sadelain (6)
  4. Boris Mueller (4)
  5. Daphna Gelblum (3)
  6. Nancy Lee (3)

More People

Years
  1. 2021 (1)
  2. 2015 (3)
  3. 2014 (1)
  4. 2013 (1)
  5. 2012 (1)
  6. 2011 (1)

More Years

Publications
  1. Blood (3)
  2. International Journal of Radiation Oncology, Biology, Physics (2)
  3. American Journal of Roentgenology (1)
  4. Annals of Oncology (1)
  5. Brachytherapy (1)
  6. Cancer Research (1)

More Publications

Publishers
  1. American Society of Hematology (3)
  2. Elsevier Inc. (2)
  3. Nature Publishing Group (2)
  4. American Association for Cancer Research (1)
  5. American College of Medical Physics (1)
  6. American Roentgen Ray Society (1)

More Publishers

Results (16)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predictors of response to very low dose radiotherapy (4Gy) for indolent B-cell lymphomas: Is 4Gy also suitable for potentially curable patients?
    Meeting Abstract

    Imber, B. S.; Chau, K. W.; Lee, J.; Lee, J.; Chelius, M.; Hajj, C.; Wijetunga, N. A.; Yang, J. C.; Casey, D. L.; Shepherd, A. F.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Omission of elective retropharyngeal nodal irradiation superior to vertebral level C1 is not associated with retropharyngeal nodal failure in N0-N2b oropharyngeal cancer patients treated with definitive chemoradiation
    Meeting Abstract

    Gutiontov, S. I.; McBride, S. M.; Riaz, N.; Gelblum, D.; Schupak, K. D.; Wolden, S. L.; Dutta, P. R.; Lee, J. E.; Lee, N.; Tsai, C. J.
    International Journal of Radiation Oncology, Biology, Physics (2015)

    Fulltext@MSK | Save
  • CD19-targeted CAR T cells "armored" to secrete IL-12 demonstrate superior efficacy against B cell acute lymphoblastic leukemia and resist treg immunosuppression
    Meeting Abstract

    Chang, P. S.; Lee, J. C.; Koneru, M.; Brentjens, R. J.
    Molecular Therapy (2015)

    Fulltext@MSK | Save
  • Clinical experience with two frameless stereotactic radiosurgery (fSRS) systems using optical surface imaging for motion monitoring
    Journal Article

    Li, G.; Ballangrud, A.; Chan, M.; Ma, R.; Beal, K.; Yamada, Y.; Chan, T.; Lee, J.; Parhar, P.; Mechalakos, J.; more...
    Journal of Applied Clinical Medical Physics (2015)

    Fulltext@MSK | Save
  • Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)
    Journal Article

    Fury, M. G.; Sherman, E. J.; Rao, S. S.; Wolden, S.; Smith-Marrone, S.; Mueller, B.; Ng, K. K.; Dutta, P. R.; Gelblum, D. Y.; Lee, J. L.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Phase I study of weekly albumin-bound paclitaxel (ab-P) plus weekly cetuximab (Cet) plus intensity-modulated radiation therapy (IMRT) in patients with stage III/IVb head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Rao, S. S.; Wolden, S. L.; Smith-Marrone, S.; Ng, K. K.; Mueller, B.; Gelblum, D. Y.; Dutta, P. R.; Lee, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
    Journal Article

    Pegram, H. J.; Lee, J. C.; Hayman, E. G.; Imperato, G. H.; Tedder, T. F.; Sadelain, M.; Brentjens, R. J.
    Blood (2012)

    Fulltext@MSK | Save
  • In vivo inhibition of human CD19-targeted effector T cells by natural T regulatory cells in a xenotransplant murine model of B cell malignancy
    Journal Article

    Lee, J. C.; Hayman, E.; Pegram, H. J.; Santos, E.; Heller, G.; Sadelain, M.; Brentjens, R.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Pilot study of a radiation oncology telemedicine platform
    Journal Article

    Mueller, B. A.; Obcemea, C.; Lee, J.; Sim, S.
    Journal of Radiation Oncology Informatics (2010)

    Fulltext@MSK | Save
  • Sensitive in vivo imaging of T cells using a membrane-bound Gaussia princeps luciferase
    Journal Article

    Santos, E. B.; Yeh, R.; Lee, J.; Nikhamin, Y.; Punzalan, B.; Perle, K. L.; Larson, S. M.; Sadelain, M.; Brentjens, R. J.
    Nature Medicine (2009)

    Fulltext@MSK | Save